Although the role of miRNAs in the cluster in cachexia remains to be elucidated, our results suggest a therapeutic potential of miR‐376c‐3p in improving Atrogin‐1‐mediated muscle atrophy in cachexia. The gene discussed is FBXO32; the disease is Cachexia.